Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Arcutis Biotherapeutics, Inc. (ARQT)
USD26.73
-0.39 (-1.44%)
US NASDAQ Healthcare Biotechnology
Address
3027 Townsgate Road 91361
Westlake Village, CA, US
Westlake Village, CA, US
CEO
Todd Franklin Watanabe
Website
arcutis.com
IPO
2020-01-31
CIK 1787306 ISIN US03969K1088
Description
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
News Sentiment (7d)
Based on only 2 articles — low confidence
- Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin Treatment Investors Business Daily
- FDA Accepts Supplemental New Drug Application for Arcutis' ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months GlobeNewsWire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD26.73
-0.39 (-1.44%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.52
Float Shares
110.27M
Free Float %
88.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.59% | -0.10% | -14.22% | -19.99% | -9.49% | -28.75% | +49.71% | +100.87% | -19.02% | -5.09% | -5.09% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
26.73
Low
34.00
+27.2%
Consensus
35.50
+32.8%
Median
35.50
+32.8%
High
37.00
+38.4%
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
34.00
+27.2%
|
| Last Year | 5 |
32.40
+21.2%
|
| All Time | 12 |
27.67
+3.5%
|
Quality scores
Altman Z-Score
4.07
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+91.3% ★ Q1'26: +60.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+88.8% ★ Q1'26: +56.4% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-12.3% Q1'26: +2.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-0.8% Q1'26: -8.6% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +171.9% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+5.2% Q1'26: +2.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×2.53× ★ Q1'26: -0.39× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 8 Rev. Ana. 6 EPS Ana. |
Dec 2029 7 Rev. Ana. 4 EPS Ana. |
Dec 2030 7 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.69M
est: 2.97M (+24.0%)
|
59.61M
est: 132.06M (-54.9%)
|
196.54M
est: 185.46M (+6.0%)
|
376.07M
est: 360.26M (+4.4%)
|
496.90M
493.77M – 498.79M
+37.9% YoY
|
645.18M
625.66M – 664.71M
+29.8% YoY
|
782.65M
782.28M – 783.01M
+21.3% YoY
|
919.71M
896.68M – 952.66M
+17.5% YoY
|
1.06B
1.03B – 1.09B
+14.8% YoY
|
| EBITDA |
-294.55M
est: -331.6K (-88,721.9%)
|
-227.43M
est: -40.97M (-455.1%)
|
-109.63M
est: -57.54M (-90.5%)
|
2.48M
est: -111.77M (+102.2%)
|
-154.16M
-154.74M – -153.18M
-37.9% YoY
|
-200.16M
-206.22M – -194.10M
-29.8% YoY
|
-242.80M
-242.92M – -242.69M
-21.3% YoY
|
-285.33M
-295.55M – -278.18M
-17.5% YoY
|
-327.63M
-339.37M – -319.43M
-14.8% YoY
|
| EBIT |
-295.81M
est: -339.5K (-87,034.0%)
|
-229.32M
est: -41.70M (-450.0%)
|
-112.22M
est: -58.56M (-91.6%)
|
-2.89M
est: -113.75M (+97.5%)
|
-156.89M
-157.49M – -155.90M
-37.9% YoY
|
-203.71M
-209.87M – -197.54M
-29.8% YoY
|
-247.11M
-247.22M – -246.99M
-21.3% YoY
|
-290.38M
-300.79M – -283.11M
-17.5% YoY
|
-333.44M
-345.38M – -325.09M
-14.8% YoY
|
| Net Income |
-311.46M
est: -717.55M (+56.6%)
|
-262.14M
est: -261.77M (-0.1%)
|
-140.04M
est: -165.10M (+15.2%)
|
-16.14M
est: -23.00M (+29.8%)
|
15.18M
-8.43M – 48.89M
+166.0% YoY
|
134.25M
113.08M – 178.92M
+784.6% YoY
|
246.43M
143.54M – 351.73M
+83.6% YoY
|
315.75M
305.47M – 330.46M
+28.1% YoY
|
369.40M
357.38M – 386.61M
+17.0% YoY
|
| SGA |
122.12M
est: 23.43M (+421.3%)
|
185.15M
est: 1.03B (-82.1%)
|
229.39M
est: 1.45B (-84.2%)
|
274.55M
est: 2.82B (-90.3%)
|
3.89B
3.86B – 3.90B
+37.9% YoY
|
5.05B
4.90B – 5.20B
+29.8% YoY
|
6.13B
6.12B – 6.13B
+21.3% YoY
|
7.20B
7.02B – 7.46B
+17.5% YoY
|
8.27B
8.06B – 8.56B
+14.8% YoY
|
| EPS |
-5.66
est: -5.93 (+4.6%)
|
-3.78
est: -2.04 (-85.0%)
|
-1.16
est: -1.32 (+12.3%)
|
-0.13
est: -0.18 (+29.6%)
|
0.20
-0.07 – 0.38
+207.6% YoY
|
1.07
0.89 – 1.41
+437.7% YoY
|
1.84
1.13 – 2.76
+72.3% YoY
|
2.48
2.40 – 2.60
+34.8% YoY
|
2.90
2.81 – 3.04
+17.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
35.90M
OE per share TTM
0.27
Owner's Yield
1.15%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
4.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
54
Total invested
138.51M
Insider transactions (90d)
5
Beneficial owners (>5%)
25
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Aaron Cowen | 9.59M | 9.99% | — | 9.59M | — | 9.59M | HC, IN | Delaware | 2023-10-30 | ↗ |
| 2 | Suvretta Capital Management, LLC | 9.59M | 9.99% | — | 9.59M | — | 9.59M | IA, OO | Delaware | 2023-10-30 | ↗ |
| 3 | Patrick J. Heron | 8.75M | 14.60% | 61.1K | 8.68M | 61.1K | 8.68M | IN | — | 2022-08-09 | ↗ |
| 4 | Averill Master Fund, Ltd. | 8.72M | 9.10% | — | 8.72M | — | 8.72M | CO | Delaware | 2023-10-30 | ↗ |
| 5 | James N. Topper | 8.71M | 14.50% | 30.6K | 8.68M | 30.6K | 8.68M | IN | — | 2022-08-09 | ↗ |
| 6 | FHM Life Sciences VIII, L.L.C. | 8.68M | 14.50% | — | 8.68M | — | 8.68M | OO | — | 2022-08-09 | ↗ |
| 7 | FHM Life Sciences VIII, L.P. | 8.68M | 14.50% | — | 8.68M | — | 8.68M | PN | — | 2022-08-09 | ↗ |
| 8 | Frazier Life Sciences VIII, L.P. | 8.68M | 14.50% | — | 8.68M | — | 8.68M | PN | — | 2022-08-09 | ↗ |
| 9 | Polar Capital Holdings Plc | 7.12M | 7.56% | 7.12M | — | 7.12M | — | HC | United Kingdom | 2023-11-16 | ↗ |
| 10 | Polar Capital LLP | 7.12M | 7.56% | 7.12M | — | 7.12M | — | IA | United Kingdom | 2023-11-16 | ↗ |
| 11 | David Rosen | 6.64M | 7.04% | — | 6.64M | — | — | IN | United States of America | 2024-02-12 | ↗ |
| 12 | Rubric Capital Management LP | 6.64M | 7.04% | — | 6.64M | — | — | IA, PN | — | 2024-02-12 | ↗ |
| 13 | Polar Capital Funds PLC - Biotechnology Fund | 6.28M | 6.67% | 6.28M | — | 6.28M | — | OO | United Kingdom | 2023-11-16 | ↗ |
| 14 | Morgan Stanley | 6.09M | 6.50% | 13.00 | 5.36M | — | 13.00 | HC, CO | — | 2024-02-12 | ↗ |
| 15 | (1) BlackRock, Inc. | 5.92M | 6.30% | 5.88M | — | 5.92M | — | HC | Delaware | 2024-01-29 | ↗ |
| 16 | The Vanguard Group - 23-1945930 | 4.90M | 5.19% | — | 129.1K | 4.73M | 164.6K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 17 | STATE STREET CORPORATION | 3.68M | 6.04% | — | 3.61M | — | 3.68M | HC | — | 2023-02-08 | ↗ |
| 18 | OrbiMed Advisors LLC | 2.83M | 4.70% | — | 2.83M | — | 10.00 | IA | — | 2022-08-26 | ↗ |
| 19 | OrbiMed Capital GP VII LLC | 2.83M | 4.70% | — | 2.83M | — | 10.00 | OO | — | 2022-08-26 | ↗ |
| 20 | Bain Capital Life Sciences Fund, L.P. | 2.72M | 5.30% | — | 2.72M | — | 2.72M | PN | — | 2022-05-27 | ↗ |
| 21 | Point72 Asset Management, L.P. | 2.64M | 4.00% | — | 2.64M | — | 2.64M | PN | — | 2022-02-14 | ↗ |
| 22 | Point72 Capital Advisors, Inc. | 2.64M | 4.00% | — | 2.64M | — | 2.64M | CO | — | 2022-02-14 | ↗ |
| 23 | BCIP Life Sciences Associates, LP | 278.6K | 0.50% | — | 278.6K | — | 278.6K | PN | — | 2022-05-27 | ↗ |
| 24 | OrbiMed Capital LLC | 48.1K | 0.10% | 48.1K | — | 48.1K | 10.00 | IA | — | 2022-08-26 | ↗ |
| 25 | 2 | 31.6K | 12.00% | — | 31.6K | — | — | OO | Delaware | 2024-01-31 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
54
-235 vs prev Q
New positions
9
Closed positions
235
Increased
29
Reduced
15
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 11.96M +1.5M (+14.2%) | 347.43M +149.9M (+75.9%) | 9.37% +1.124 pp | 7.12% +2.062 pp | USD8.95 +224.5% | 12 qtrs — |
| 2 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 9.87M +— (+0.0%) | 286.76M +100.6M (+54.1%) | 7.74% -0.038 pp | 7.70% +2.125 pp | USD18.53 +56.7% | 16 qtrs — |
| 3 | BLACKROCK, INC. | 9.10M +525.6K (+6.1%) | 264.25M +102.6M (+63.5%) | 7.13% +0.379 pp | 0.00% +0.002 pp | USD10.54 +175.5% | 6 qtrs — |
| 4 | RUBRIC CAPITAL MANAGEMENT LP | 8.27M -2.5M (-23.1%) | 240.21M +37.6M (+18.5%) | 6.48% -1.983 pp | 2.87% +0.586 pp | USD10.19 +185.0% | 15 qtrs — |
| 5 | VANGUARD GROUP INC | 7.25M +107.8K (+1.5%) | 210.65M +76.0M (+56.4%) | 5.68% +0.057 pp | 0.00% +0.001 pp | USD13.60 +113.5% | 24 qtrs — |
| 6 | JENNISON ASSOCIATES LLC | 6.76M -5.5M (-44.9%) | 196.25M -34.7M (-15.0%) | 5.30% -4.354 pp | 0.12% -0.017 pp | USD9.65 +200.9% | 15 qtrs — |
| 7 | POLAR CAPITAL HOLDINGS PLC | 5.56M +257.4K (+4.9%) | 161.35M +61.5M (+61.5%) | 4.35% +0.181 pp | 0.62% +0.143 pp | USD12.25 +137.1% | 21 qtrs — |
| 8 | STATE STREET CORP | 5.49M +847.0K (+18.2%) | 159.38M +71.9M (+82.2%) | 4.30% +0.646 pp | 0.01% +0.002 pp | USD13.85 +109.7% | 24 qtrs — |
| 9 | GILDER GAGNON HOWE & CO LLC | 4.45M +24.7K (+0.6%) | 129.34M +45.9M (+54.9%) | 3.49% +0.002 pp | 1.37% +0.515 pp | USD11.00 +164.0% | 8 qtrs — |
| 10 | MORGAN STANLEY | 4.34M +63.8K (+1.5%) | 126.04M +45.4M (+56.4%) | 3.40% +0.034 pp | 0.01% +0.003 pp | USD6.12 +374.5% | 24 qtrs — |
| 11 | UBS GROUP AG | 3.24M +295.0K (+10.0%) | 94.19M +38.6M (+69.5%) | 2.54% +0.220 pp | 0.02% +0.007 pp | USD15.10 +92.3% | 24 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.75M +146.8K (+5.6%) | 79.97M +30.8M (+62.7%) | 2.16% +0.105 pp | 0.00% +0.002 pp | USD13.57 +114.0% | 24 qtrs — |
| 13 | D. E. SHAW & CO., INC. | 2.68M +564.4K (+26.6%) | 77.92M +38.0M (+95.1%) | 2.10% +0.434 pp | 0.04% +0.020 pp | USD14.86 +95.4% | 8 qtrs — |
| 14 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.56M +1.5M (+133.6%) | 74.41M +53.7M (+259.9%) | 2.01% +1.144 pp | 0.51% +0.357 pp | USD22.59 +28.6% | 5 qtrs — |
| 15 | ENSIGN PEAK ADVISORS, INC | 1.90M -90.7K (-4.5%) | 55.25M +17.7M (+47.1%) | 1.49% -0.079 pp | 0.10% +0.036 pp | USD9.48 +206.3% | 24 qtrs — |
| 16 | FRANKLIN RESOURCES INC | 1.90M -410.9K (-17.8%) | 55.18M +11.6M (+26.7%) | 1.49% -0.331 pp | 0.01% +0.003 pp | USD7.47 +288.8% | 20 qtrs — |
| 17 | JANUS HENDERSON GROUP PLC | 1.83M -568.0K (-23.7%) | 53.15M +8.0M (+17.7%) | 1.43% -0.454 pp | 0.02% +0.003 pp | USD14.19 +104.7% | 7 qtrs — |
| 18 | BANK OF AMERICA CORP /DE/ | 1.67M +784.2K (+88.2%) | 48.60M +31.8M (+189.9%) | 1.31% +0.611 pp | 0.00% +0.002 pp | USD20.05 +44.8% | 24 qtrs — |
| 19 | GOLDMAN SACHS GROUP INC | 1.58M -228.6K (-12.7%) | 45.78M +11.8M (+34.5%) | 1.24% -0.186 pp | 0.01% +0.002 pp | USD10.83 +168.1% | 24 qtrs — |
| 20 | AMERICAN CENTURY COMPANIES INC | 1.47M -195.3K (-11.7%) | 42.61M +11.3M (+36.0%) | 1.15% -0.159 pp | 0.02% +0.006 pp | USD13.44 +116.1% | 21 qtrs — |
| 21 | NUVEEN, LLC | 1.38M +11.8K (+0.9%) | 40.14M +14.3M (+55.4%) | 1.08% +0.004 pp | 0.01% +0.004 pp | USD17.16 +69.2% | 4 qtrs — |
| 22 | PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.37M -753.9K (-35.6%) | 39.69M -284.8K (-0.7%) | 1.07% -0.599 pp | 15.34% -7.764 pp | USD12.13 +139.4% | 21 qtrs — |
| 23 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.17M +1.1M (+1,228.4%) | 33.87M +32.2M (+1,945.4%) | 0.91% +0.845 pp | 0.00% +0.004 pp | USD27.94 +3.9% | 24 qtrs — |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.01M +15.4K (+1.5%) | 29.47M +10.6M (+56.4%) | 0.80% +0.008 pp | 0.00% +0.002 pp | USD14.03 +107.0% | 24 qtrs — |
| 25 | GW&K INVESTMENT MANAGEMENT, LLC | 1.01M -163.5K (-13.9%) | 29.29M +7.2M (+32.6%) | 0.79% -0.133 pp | 0.25% +0.058 pp | USD15.82 +83.6% | 16 qtrs — |
| 26 | NORTHERN TRUST CORP | 955.2K +15.0K (+1.6%) | 27.74M +10.0M (+56.5%) | 0.75% +0.008 pp | 0.00% +0.001 pp | USD14.81 +96.1% | 24 qtrs — |
| 27 | DEUTSCHE BANK AG\ | 930.2K +552.7K (+146.4%) | 27.01M +19.9M (+279.6%) | 0.73% +0.432 pp | 0.01% +0.006 pp | USD19.49 +49.0% | 24 qtrs — |
| 28 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 914.0K +80.5K (+9.7%) | 26.54M +10.8M (+68.9%) | 0.72% +0.060 pp | 0.09% +0.041 pp | USD19.75 +47.0% | 8 qtrs — |
| 29 | PERPETUAL LTD | 910.6K -1.1M (-55.0%) | 26.44M -11.7M (-30.7%) | 0.71% -0.881 pp | 0.38% -0.091 pp | USD18.81 +54.4% | 4 qtrs — |
| 30 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 900.0K +900.0K (+100.0%) | 26.14M +26.1M (+100.0%) | 0.71% +0.705 pp | 0.04% +0.044 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 31 | FEDERATED HERMES, INC. | 891.8K +132.2K (+17.4%) | 25.90M +11.6M (+80.9%) | 0.70% +0.101 pp | 0.04% +0.018 pp | USD12.18 +138.4% | 13 qtrs — |
| 32 | OBERWEIS ASSET MANAGEMENT INC/ | 808.4K +808.4K (+100.0%) | 23.48M +23.5M (+100.0%) | 0.63% +0.633 pp | 0.86% +0.858 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 33 | CANDRIAM S.C.A. | 803.1K +25.1K (+3.2%) | 23.32M +8.7M (+59.0%) | 0.63% +0.017 pp | 0.12% +0.039 pp | USD10.15 +186.1% | 7 qtrs — |
| 34 | BNP PARIBAS ARBITRAGE, SNC | 699.8K +653.7K (+1,416.5%) | 20.32M +19.5M (+2,236.3%) | 0.55% +0.512 pp | 0.01% +0.009 pp | USD28.29 +2.7% | 5 qtrs — |
| 35 | QUBE RESEARCH & TECHNOLOGIES LTD | 661.4K -153.2K (-18.8%) | 19.21M +3.9M (+25.1%) | 0.52% -0.123 pp | 0.02% +0.004 pp | USD15.81 +83.7% | 6 qtrs — |
| 36 | NEARWATER CAPITAL MARKETS, LTD | 615.0K +615.0K (+100.0%) | 17.86M +17.9M (+100.0%) | 0.48% +0.482 pp | 0.31% +0.305 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 37 | ABRDN PLC | 586.4K -88.6K (-13.1%) | 17.03M +4.3M (+33.8%) | 0.46% -0.072 pp | 0.03% +0.006 pp | USD9.56 +203.8% | 9 qtrs — |
| 38 | FISHMAN JAY A LTD/MI | 564.7K -1.0K (-0.2%) | 16.40M +5.7M (+53.8%) | 0.44% -0.003 pp | 1.35% +0.435 pp | USD18.85 +54.1% | 2 qtrs — |
| 39 | BIOIMPACT CAPITAL LLC | 531.2K +531.2K (+100.0%) | 15.43M +15.4M (+100.0%) | 0.42% +0.416 pp | 1.77% +1.765 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 40 | BAMCO INC /NY/ | 504.7K +504.7K (+100.0%) | 14.66M +14.7M (+100.0%) | 0.40% +0.396 pp | 0.04% +0.040 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 41 | CORMORANT ASSET MANAGEMENT, LP | 500.0K -275.0K (-35.5%) | 14.52M -88.8K (-0.6%) | 0.39% -0.219 pp | 0.67% -0.337 pp | USD9.66 +200.6% | 8 qtrs — |
| 42 | CAPITOLIS LIQUID GLOBAL MARKETS LLC | 500.0K +500.0K (+100.0%) | 14.52M +14.5M (+100.0%) | 0.39% +0.392 pp | 0.09% +0.087 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 43 | AQR CAPITAL MANAGEMENT LLC | 499.4K +58.1K (+13.2%) | 14.50M +6.2M (+74.3%) | 0.39% +0.044 pp | 0.01% +0.002 pp | USD14.41 +101.5% | 9 qtrs — |
| 44 | SQUAREPOINT OPS LLC | 455.9K +296.0K (+185.2%) | 13.24M +10.2M (+339.4%) | 0.36% +0.231 pp | 0.01% +0.011 pp | USD23.40 +24.1% | 10 qtrs — |
| 45 | MARSHALL WACE, LLP | 454.2K +435.9K (+2,382.1%) | 13.19M +12.8M (+3,724.0%) | 0.36% +0.342 pp | 0.01% +0.012 pp | USD28.63 +1.4% | 4 qtrs — |
| 46 | EVERSEPT PARTNERS, LP | 434.6K +323.2K (+289.9%) | 12.62M +10.5M (+500.7%) | 0.34% +0.253 pp | 0.64% +0.491 pp | USD26.43 +9.9% | 2 qtrs — |
| 47 | JUMP FINANCIAL, LLC | 430.9K +80.4K (+22.9%) | 12.51M +5.9M (+89.4%) | 0.34% +0.062 pp | 0.15% +0.075 pp | USD20.62 +40.8% | 13 qtrs — |
| 48 | POINT72 ASSET MANAGEMENT, L.P. | 425.2K +425.2K (+100.0%) | 12.35M +12.3M (+100.0%) | 0.33% +0.333 pp | 0.01% +0.014 pp | USD29.04 +0.0% | 6 qtrs — |
| 49 | ZEVENBERGEN CAPITAL INVESTMENTS LLC | 418.0K +418.0K (+100.0%) | 12.14M +12.1M (+100.0%) | 0.33% +0.328 pp | 0.27% +0.270 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 50 | FIRST TRUST ADVISORS LP | 404.7K +179.7K (+79.9%) | 11.75M +7.5M (+177.1%) | 0.32% +0.140 pp | 0.01% +0.005 pp | USD21.02 +38.2% | 5 qtrs — |
| 51 | TWO SIGMA INVESTMENTS, LP | 400.9K +305.4K (+320.1%) | 11.64M +9.8M (+547.1%) | 0.31% +0.239 pp | 0.02% +0.014 pp | USD24.95 +16.4% | 9 qtrs — |
| 52 | BARCLAYS PLC | 331.6K +78.2K (+30.9%) | 9.63M +7.3M (+308.6%) | 0.26% +0.060 pp | 0.00% +0.002 pp | USD16.59 +75.0% | 16 qtrs — |
| 53 | JUPITER ASSET MANAGEMENT LTD | 326.5K -332.8K (-50.5%) | 9.48M -2.9M (-23.7%) | 0.26% -0.263 pp | 0.08% -0.031 pp | USD15.83 +83.4% | 3 qtrs — |
| 54 | CASTLEARK MANAGEMENT LLC | 309.4K +309.4K (+100.0%) | 8.99M +9.0M (+100.0%) | 0.24% +0.243 pp | 0.26% +0.264 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 55 | INVESCO LTD. | 307.4K +114.4K (+59.3%) | 8.93M +5.3M (+145.4%) | 0.24% +0.089 pp | 0.00% +0.001 pp | USD20.21 +43.7% | 19 qtrs — |
| 56 | PRIVIUM FUND MANAGEMENT B.V. | 306.0K +— (+0.0%) | 8.89M +3.1M (+54.1%) | 0.24% -0.001 pp | 1.64% +0.599 pp | USD13.93 +108.5% | 5 qtrs — |
| 57 | BANK OF NEW YORK MELLON CORP | 304.4K -6.2K (-2.0%) | 8.84M +3.0M (+51.0%) | 0.24% -0.006 pp | 0.00% +0.000 pp | USD13.47 +115.6% | 24 qtrs — |
| 58 | WELLS FARGO & COMPANY/MN | 284.2K +179.0K (+170.0%) | 8.25M +6.3M (+316.0%) | 0.22% +0.140 pp | 0.00% +0.001 pp | USD23.68 +22.6% | 24 qtrs — |
| 59 | RENAISSANCE TECHNOLOGIES LLC | 274.0K +274.0K (+100.0%) | 7.96M +8.0M (+100.0%) | 0.21% +0.215 pp | 0.01% +0.012 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 60 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 272.4K +139.2K (+104.5%) | 7.91M +5.4M (+215.1%) | 0.21% +0.109 pp | 0.00% +0.001 pp | USD21.49 +35.1% | 19 qtrs — |
| 61 | MYDA ADVISORS LLC | 265.0K -205.0K (-43.6%) | 7.70M -1.2M (-13.1%) | 0.21% -0.162 pp | 1.47% -0.447 pp | USD13.17 +120.5% | 9 qtrs — |
| 62 | MILLENNIUM MANAGEMENT LLC | 236.8K +86.7K (+57.7%) | 6.88M +4.0M (+143.0%) | 0.19% +0.067 pp | 0.00% +0.002 pp | USD18.42 +57.7% | 10 qtrs — |
| 63 | PRUDENTIAL FINANCIAL INC | 234.9K +221.0K (+1,585.8%) | 6.82M +6.6M (+2,497.1%) | 0.18% +0.173 pp | 0.01% +0.008 pp | USD27.77 +4.6% | 15 qtrs — |
| 64 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 234.1K +147.6K (+170.6%) | 6.80M +5.2M (+317.0%) | 0.18% +0.115 pp | 0.01% +0.008 pp | USD25.27 +14.9% | 2 qtrs — |
| 65 | UBS ASSET MANAGEMENT AMERICAS INC | 231.7K -12.3K (-5.0%) | 6.73M +2.1M (+46.3%) | 0.18% -0.011 pp | 0.00% +0.000 pp | USD10.98 +164.5% | 7 qtrs — |
| 66 | STEMPOINT CAPITAL LP | 224.7K -187.2K (-45.4%) | 6.53M -1.2M (-15.9%) | 0.18% -0.148 pp | 1.12% -0.437 pp | USD12.44 +133.4% | 9 qtrs — |
| 67 | EAM INVESTORS, LLC | 213.9K +213.9K (+100.0%) | 6.21M +6.2M (+100.0%) | 0.17% +0.168 pp | 0.69% +0.692 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 68 | SWISS NATIONAL BANK | 212.8K +4.9K (+2.4%) | 6.18M +2.3M (+57.7%) | 0.17% +0.003 pp | 0.00% +0.001 pp | USD10.25 +183.3% | 7 qtrs — |
| 69 | PATIENT SQUARE CAPITAL LP | 210.0K +210.0K (+100.0%) | 6.10M +6.1M (+100.0%) | 0.16% +0.165 pp | 1.31% +1.306 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 70 | FMR LLC | 205.4K +37.5K (+22.3%) | 5.97M +2.8M (+88.4%) | 0.16% +0.029 pp | 0.00% +0.000 pp | USD23.80 +22.0% | 24 qtrs — |
| 71 | NORDEA INVESTMENT MANAGEMENT AB | 201.6K +201.6K (+100.0%) | 5.85M +5.8M (+100.0%) | 0.16% +0.158 pp | 0.01% +0.005 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 72 | WOODLINE PARTNERS LP | 195.0K -119.6K (-38.0%) | 5.66M -266.8K (-4.5%) | 0.15% -0.095 pp | 0.02% -0.006 pp | USD16.75 +73.4% | 4 qtrs — |
| 73 | HILLSDALE INVESTMENT MANAGEMENT INC. | 179.4K +179.4K (+100.0%) | 5.21M +5.2M (+100.0%) | 0.14% +0.141 pp | 0.14% +0.144 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 74 | VOLEON CAPITAL MANAGEMENT LP | 176.6K +151.8K (+611.1%) | 5.13M +4.7M (+995.5%) | 0.14% +0.119 pp | 0.11% +0.099 pp | USD27.61 +5.2% | 2 qtrs — |
| 75 | NORGES BANK | 174.8K +174.8K (+100.0%) | 5.08M +5.1M (+100.0%) | 0.14% +0.137 pp | 0.00% +0.001 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 76 | RAFFERTY ASSET MANAGEMENT, LLC | 172.1K +23.8K (+16.0%) | 5.00M +2.2M (+78.8%) | 0.13% +0.018 pp | 0.02% +0.008 pp | USD12.33 +135.5% | 21 qtrs — |
| 77 | WALLEYE CAPITAL LLC | 168.6K +147.9K (+714.4%) | 4.90M +4.5M (+1,154.7%) | 0.13% +0.116 pp | 0.02% +0.014 pp | USD27.20 +6.8% | 4 qtrs — |
| 78 | RHUMBLINE ADVISERS | 161.4K -21.7K (-11.9%) | 4.69M +1.2M (+35.8%) | 0.13% -0.018 pp | 0.00% +0.001 pp | USD13.56 +114.2% | 24 qtrs — |
| 79 | TWO SIGMA ADVISERS, LP | 156.1K +141.0K (+933.8%) | 4.53M +4.2M (+1,492.6%) | 0.12% +0.110 pp | 0.01% +0.008 pp | USD27.74 +4.7% | 8 qtrs — |
| 80 | CITADEL ADVISORS LLC | 155.2K -22.1K (-12.5%) | 4.51M +1.2M (+34.8%) | 0.12% -0.018 pp | 0.00% +0.000 pp | USD14.80 +96.2% | 24 qtrs — |
| 81 | PDT PARTNERS, LLC | 155.1K +967.0 (+0.6%) | 4.50M +1.6M (+55.0%) | 0.12% +0.000 pp | 0.29% +0.109 pp | USD9.80 +196.3% | 14 qtrs — |
| 82 | RAYMOND JAMES FINANCIAL INC | 144.9K +84.9K (+141.3%) | 4.21M +3.1M (+271.7%) | 0.11% +0.066 pp | 0.00% +0.001 pp | USD23.63 +22.9% | 4 qtrs — |
| 83 | ESSEX INVESTMENT MANAGEMENT CO LLC | 141.3K -55.0K (-28.0%) | 4.10M +403.0K (+10.9%) | 0.11% -0.044 pp | 0.63% +0.059 pp | USD11.35 +155.9% | 7 qtrs — |
| 84 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 126.0K +70.0K (+124.9%) | 3.59M +2.5M (+239.9%) | 0.10% +0.055 pp | 0.00% +0.002 pp | USD21.91 +32.5% | 22 qtrs — |
| 85 | ALLIANCEBERNSTEIN L.P. | 116.4K +3.0K (+2.6%) | 3.38M +1.2M (+58.1%) | 0.09% +0.002 pp | 0.00% +0.000 pp | USD12.87 +125.6% | 24 qtrs — |
| 86 | KORNITZER CAPITAL MANAGEMENT INC /KS | 113.4K +113.4K (+100.0%) | 3.29M +3.3M (+100.0%) | 0.09% +0.089 pp | 0.07% +0.068 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 87 | LPL FINANCIAL LLC | 111.9K -5.1K (-4.3%) | 3.25M +1.0M (+47.4%) | 0.09% -0.004 pp | 0.00% +0.000 pp | USD5.35 +442.8% | 11 qtrs — |
| 88 | JPMORGAN CHASE & CO | 106.5K +5.7K (+5.6%) | 3.09M +1.2M (+62.8%) | 0.08% +0.004 pp | 0.00% +0.000 pp | USD11.12 +161.2% | 24 qtrs — |
| 89 | TUDOR INVESTMENT CORP ET AL | 106.1K +36.2K (+51.7%) | 3.08M +1.8M (+133.7%) | 0.08% +0.028 pp | 0.01% +0.003 pp | USD22.32 +30.1% | 14 qtrs — |
| 90 | SEI INVESTMENTS CO | 104.3K +78.4K (+303.2%) | 3.03M +2.5M (+521.2%) | 0.08% +0.061 pp | 0.00% +0.003 pp | USD26.14 +11.1% | 4 qtrs — |
| 91 | LEGAL & GENERAL GROUP PLC | 104.0K -5.4K (-5.0%) | 3.02M +957.5K (+46.4%) | 0.08% -0.005 pp | 0.00% +0.000 pp | USD10.03 +189.5% | 24 qtrs — |
| 92 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 102.4K -1.9K (-1.8%) | 2.97M +1.0M (+51.3%) | 0.08% -0.002 pp | 0.00% +0.001 pp | USD11.29 +157.2% | 24 qtrs — |
| 93 | STATE OF WISCONSIN INVESTMENT BOARD | 99.2K -24.7K (-19.9%) | 2.88M +545.5K (+23.3%) | 0.08% -0.020 pp | 0.01% +0.001 pp | USD13.42 +116.4% | 7 qtrs — |
| 94 | AMERIPRISE FINANCIAL INC | 98.8K -359.0 (-0.4%) | 2.87M +1.0M (+53.5%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD7.63 +280.6% | 24 qtrs — |
| 95 | JANE STREET GROUP, LLC | 97.8K +50.5K (+106.8%) | 2.84M +1.9M (+218.5%) | 0.08% +0.039 pp | 0.00% +0.000 pp | USD20.65 +40.6% | 6 qtrs — |
| 96 | TD ASSET MANAGEMENT INC | 97.2K +97.2K (+100.0%) | 2.82M +2.8M (+100.0%) | 0.08% +0.076 pp | 0.00% +0.002 pp | USD29.04 +0.0% | 1 qtrs NEW |
| 97 | LAZARD ASSET MANAGEMENT LLC | 93.4K -186.3K (-66.6%) | 2.71M -2.6M (-48.6%) | 0.07% -0.147 pp | 0.00% -0.003 pp | USD9.56 +203.8% | 7 qtrs — |
| 98 | DEKABANK DEUTSCHE GIROZENTRALE | 140.0K +— (+0.0%) | 1.46M +15.0K (+1.0%) | 0.11% -0.001 pp | 0.00% +0.000 pp | USD3.23 +799.1% | 9 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
7
Shares acquired
—
Shares disposed
30.6K
Cash buys
—
Cash sales
7.00
Net activity
-30,597
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 3,172 | 23.61 | 74.9K | 720,755 | D | ↗ |
| 2026-05-04 | Vairavan Latha | Officer | S-Sale | D | Common Stock | 1,341 | 23.61 | 31.7K | 86,413 | D | ↗ |
| 2026-05-04 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 7,372 | 23.27 | 171.5K | 127,573 | D | ↗ |
| 2026-05-04 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 684 | 23.61 | 16.1K | 120,466 | D | ↗ |
| 2026-05-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 7,144 | 22.99 | 164.2K | 32,600 | D | ↗ |
| 2026-04-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 23.88 | 238.8K | 39,744 | D | ↗ |
| 2026-03-02 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 25.65 | 256.5K | 49,744 | D | ↗ |
| 2026-03-02 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 1,068 | 25.91 | 27.7K | 785,957 | D | ↗ |
| 2026-03-02 | Vairavan Latha | Officer | S-Sale | D | Common Stock | 2,772 | 25.16 | 69.7K | 87,835 | D | ↗ |
| 2026-03-02 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 193 | 25.91 | 5.0K | 136,932 | D | ↗ |
| 2026-03-02 | Leonard Keith R | Director | M-Exempt | D | Stock Option (right to buy) | 27,052 | 8.63 | 233.5K | 0 | D | ↗ |
| 2026-03-02 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 103 | 25.91 | 2.7K | 175,178 | D | ↗ |
| 2026-03-02 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 6,106 | 25.16 | 153.6K | 121,295 | D | ↗ |
| 2026-02-27 | Watanabe Todd | Director / Officer | A-Award | A | Stock Option (right to buy) | 266,000 | 26.97 | 7.17M | 266,000 | D | ↗ |
| 2026-02-27 | Vairavan Latha | Officer | A-Award | A | Common Stock | 27,000 | 0.00 | — | 90,607 | D | ↗ |
| 2026-02-27 | Matsuda Masaru | Officer | A-Award | A | Stock Option (right to buy) | 97,000 | 26.97 | 2.62M | 97,000 | D | ↗ |
| 2026-02-27 | Edwards Larry Todd | Officer | A-Award | A | Stock Option (right to buy) | 77,000 | 26.97 | 2.08M | 77,000 | D | ↗ |
| 2026-02-27 | Burnett Patrick | Officer | A-Award | A | Stock Option (right to buy) | 77,000 | 26.97 | 2.08M | 77,000 | D | ↗ |
| 2026-02-04 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 9,794 | 25.81 | 252.7K | 80,651 | D | ↗ |
| 2026-02-02 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 25.05 | 250.5K | 59,744 | D | ↗ |
| 2026-02-02 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 19,833 | 25.50 | 505.7K | 721,306 | D | ↗ |
| 2026-02-02 | Vairavan Latha | Officer | S-Sale | D | Common Stock | 1,320 | 25.50 | 33.7K | 63,607 | D | ↗ |
| 2026-02-02 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 4,714 | 25.63 | 120.8K | 110,003 | D | ↗ |
| 2026-02-02 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 2,052 | 25.50 | 52.3K | 148,865 | D | ↗ |
| 2026-02-02 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 3,675 | 25.50 | 93.7K | 90,445 | D | ↗ |
| 2026-01-05 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 2,490 | 28.98 | 72.2K | 94,120 | D | ↗ |
| 2026-01-02 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 28.96 | 289.6K | 69,744 | D | ↗ |
| 2025-12-31 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 541 | 28.81 | 15.6K | 97,766 | D | ↗ |
| 2025-12-15 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 11,500 | 28.94 | 332.9K | 98,307 | D | ↗ |
| 2025-12-04 | Munshi Amit | Director | A-Award | A | Stock Option (right to buy) | 16,502 | 31.16 | 514.2K | 16,502 | D | ↗ |
| 2025-12-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 30.21 | 302.1K | 79,744 | D | ↗ |
| 2025-12-01 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 1,657 | 30.23 | 50.1K | 150,641 | D | ↗ |
| 2025-11-24 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 48,945 | 30.36 | 1.49M | 740,537 | D | ↗ |
| 2025-11-24 | LIN SUE-JEAN | Director | S-Sale | D | Common Stock | 25,272 | 30.78 | 778.0K | 26,735 | D | ↗ |
| 2025-11-21 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 1,055 | 30.00 | 31.7K | 793,838 | D | ↗ |
| 2025-11-20 | Gilbert Halley E | Director | M-Exempt | A | Common Stock | 12,220 | 7.51 | 91.8K | 38,655 | D | ↗ |
| 2025-11-19 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 989 | 27.95 | 27.6K | 153,037 | D | ↗ |
| 2025-11-13 | Leonard Keith R | Director | G-Gift | D | Common Stock | 4,312 | 0.00 | — | 22,123 | D | ↗ |
| 2025-11-13 | Krishnamohan Neha | Director | M-Exempt | D | Stock Option (right to buy) | 27,052 | 8.63 | 233.5K | 0 | D | ↗ |
| 2025-11-06 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 29,131 | 25.16 | 732.9K | 150,193 | D | ↗ |
| 2025-11-06 | Burnett Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 17,250 | 3.64 | 62.8K | 155,250 | D | ↗ |
| 2025-11-05 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 3,864 | 23.72 | 91.6K | 98,325 | D | ↗ |
| 2025-11-03 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 25.27 | 252.7K | 89,744 | D | ↗ |
| 2025-11-03 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 11,478 | 24.71 | 283.6K | 794,962 | D | ↗ |
| 2025-11-03 | Vairavan Latha | Officer | S-Sale | D | Common Stock | 88 | 24.72 | 2.2K | 64,927 | D | ↗ |
| 2025-11-03 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 43 | 25.40 | 1.1K | 154,026 | D | ↗ |
| 2025-11-03 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 15 | 25.40 | 381.00 | 102,189 | D | ↗ |
| 2025-10-28 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 40,000 | 25.03 | 1.00M | 806,440 | D | ↗ |
| 2025-10-02 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 20,739 | 20.04 | 415.6K | 846,440 | D | ↗ |
| 2025-10-02 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 297 | 20.78 | 6.2K | 179,324 | D | ↗ |
| 2025-10-01 | Welgus Howard G. | Director | M-Exempt | A | Common Stock | 9,538 | 1.68 | 16.0K | 109,744 | D | ↗ |
| 2025-10-01 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 15,000 | 18.91 | 283.7K | 876,440 | D | ↗ |
| 2025-09-09 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 504 | 17.52 | 8.8K | 891,440 | D | ↗ |
| 2025-09-08 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 9,625 | 17.54 | 168.8K | 891,944 | D | ↗ |
| 2025-09-04 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 36,130 | 16.16 | 583.7K | 161,234 | D | ↗ |
| 2025-09-02 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 15.64 | 156.4K | 100,206 | D | ↗ |
| 2025-08-21 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 2,438 | 15.57 | 38.0K | 104,811 | D | ↗ |
| 2025-08-19 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 1,750 | 16.16 | 28.3K | 107,249 | D | ↗ |
| 2025-08-08 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 3,847 | 14.03 | 54.0K | 108,999 | D | ↗ |
| 2025-08-04 | Watanabe Todd | Director / Officer | S-Sale | D | Common Stock | 11,547 | 14.33 | 165.4K | 901,569 | D | ↗ |
| 2025-08-04 | Vairavan Latha | Officer | S-Sale | D | Common Stock | 89 | 14.33 | 1.3K | 65,015 | D | ↗ |
| 2025-08-04 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 6,330 | 14.33 | 90.7K | 197,364 | D | ↗ |
| 2025-08-04 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 2,622 | 14.33 | 37.6K | 112,846 | D | ↗ |
| 2025-08-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 3,890 | 14.30 | 55.6K | 100,206 | D | ↗ |
| 2025-07-14 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 5,750 | 15.07 | 86.7K | 115,468 | D | ↗ |
| 2025-07-10 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 23,000 | 15.05 | 346.0K | 115,468 | D | ↗ |
| 2025-07-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 9,208 | 13.84 | 127.4K | 100,206 | D | ↗ |
| 2025-06-18 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,139 | 13.37 | 135.6K | 109,414 | D | ↗ |
| 2025-06-13 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 2,646 | 13.08 | 34.6K | 27,448 | I | ↗ |
| 2025-06-12 | Welgus Howard G. | Director | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-12 | Leonard Keith R | Director | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-12 | LIN SUE-JEAN | Director | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-12 | Krishnamohan Neha | Director | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-12 | Heron Patrick J | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-12 | Gilbert Halley E | Director | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-12 | Curran Terrie | Director | A-Award | A | Common Stock | 7,609 | 0.00 | — | 17,748 | D | ↗ |
| 2025-06-12 | CHAUDHURI BHASKAR | Director | A-Award | A | Stock Option (right to buy) | 20,568 | 13.50 | 277.7K | 20,568 | D | ↗ |
| 2025-06-10 | Watanabe Todd Franklin | Director / Officer | G-Gift | A | Common Stock | 997 | 0.00 | — | 25,410 | I | ↗ |
| 2025-06-05 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 378 | 13.41 | 5.1K | 24,802 | I | ↗ |
| 2025-06-04 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 1,890 | 13.32 | 25.2K | 24,424 | I | ↗ |
| 2025-05-28 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 1,800 | 13.78 | 24.8K | 202,599 | D | ↗ |
| 2025-05-22 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 2,520 | 13.65 | 34.4K | 22,534 | I | ↗ |
| 2025-05-21 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 2,520 | 13.66 | 34.4K | 20,014 | I | ↗ |
| 2025-05-19 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 7,451 | 14.07 | 104.8K | 183,104 | D | ↗ |
| 2025-05-15 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 2,520 | 13.62 | 34.3K | 17,494 | I | ↗ |
| 2025-05-14 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 6,300 | 13.76 | 86.7K | 14,974 | I | ↗ |
| 2025-05-13 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 2,374 | 13.76 | 32.7K | 8,674 | I | ↗ |
| 2025-05-09 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 6,300 | 13.60 | 85.7K | 6,300 | I | ↗ |
| 2025-05-08 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 3,871 | 13.59 | 52.6K | 115,468 | D | ↗ |
| 2025-05-06 | Vairavan Latha | Officer | — | — | Common Stock | 0 | 0.00 | — | 45,104 | D | ↗ |
| 2025-05-02 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 11,448 | 15.19 | 173.9K | 913,795 | D | ↗ |
| 2025-05-02 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 5,030 | 15.20 | 76.5K | 204,399 | D | ↗ |
| 2025-05-02 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 2,597 | 15.19 | 39.4K | 119,339 | D | ↗ |
| 2025-05-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 14.64 | 146.4K | 111,944 | D | ↗ |
| 2025-04-02 | Topper David Joseph | Officer | S-Sale | D | Common Stock | 9,600 | 15.80 | 151.7K | 182,774 | D | ↗ |
| 2025-04-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 15.12 | 151.2K | 121,944 | D | ↗ |
| 2025-03-25 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 2,171 | 17.56 | 38.1K | 925,243 | D | ↗ |
| 2025-03-24 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 1,500 | 17.52 | 26.3K | 927,414 | D | ↗ |
| 2025-03-17 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 1,200 | 17.61 | 21.1K | 928,914 | D | ↗ |
| 2025-03-14 | Burnett Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 12,242 | 3.64 | 44.6K | 201,250 | D | ↗ |
| 2025-03-13 | Burnett Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 5,008 | 3.64 | 18.2K | 213,492 | D | ↗ |
| 2025-03-04 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 4,135 | 13.28 | 54.9K | 930,114 | D | ↗ |
| 2025-03-04 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 954 | 13.28 | 12.7K | 166,089 | D | ↗ |
| 2025-03-03 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 13.00 | 130.0K | 131,944 | D | ↗ |
| 2025-03-03 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 20,880 | 13.03 | 272.1K | 934,249 | D | ↗ |
| 2025-03-03 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 3,263 | 13.03 | 42.5K | 209,429 | D | ↗ |
| 2025-03-03 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 2,819 | 13.03 | 36.7K | 167,043 | D | ↗ |
| 2025-02-28 | Watanabe Todd Franklin | Director / Officer | A-Award | A | Stock Option (right to buy) | 396,000 | 13.69 | 5.42M | 396,000 | D | ↗ |
| 2025-02-28 | Topper David Joseph | Officer | A-Award | A | Stock Option (right to buy) | 89,000 | 13.69 | 1.22M | 89,000 | D | ↗ |
| 2025-02-28 | Matsuda Masaru | Officer | A-Award | A | Common Stock | 34,000 | 0.00 | — | 212,692 | D | ↗ |
| 2025-02-28 | Edwards Larry Todd | Officer | A-Award | A | Stock Option (right to buy) | 43,000 | 13.69 | 588.7K | 43,000 | D | ↗ |
| 2025-02-28 | Burnett Patrick | Officer | A-Award | A | Stock Option (right to buy) | 43,000 | 13.69 | 588.7K | 43,000 | D | ↗ |
| 2025-02-03 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 12.71 | 127.1K | 141,944 | D | ↗ |
| 2025-02-03 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 19,301 | 12.70 | 245.1K | 804,129 | D | ↗ |
| 2025-02-03 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 8,338 | 12.70 | 105.9K | 178,692 | D | ↗ |
| 2025-02-03 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 2,173 | 12.70 | 27.6K | 135,555 | D | ↗ |
| 2025-02-03 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 12,116 | 12.70 | 153.9K | 114,862 | D | ↗ |
| 2025-01-02 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 14.67 | 146.7K | 151,944 | D | ↗ |
| 2024-12-31 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 1,691 | 14.00 | 23.7K | 126,978 | D | ↗ |
| 2024-12-20 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 15,000 | 15.17 | 227.6K | 823,430 | D | ↗ |
| 2024-12-02 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 12.51 | 125.1K | 161,944 | D | ↗ |
| 2024-11-30 | Watanabe Todd Franklin | Director / Officer | P-Purchase | A | Common Stock | 2,038 | 7.11 | 14.5K | 838,430 | D | ↗ |
| 2024-11-30 | Matsuda Masaru | Officer | P-Purchase | A | Common Stock | 1,657 | 7.11 | 11.8K | 187,030 | D | ↗ |
| 2024-11-30 | Edwards Larry Todd | Officer | P-Purchase | A | Common Stock | 1,093 | 7.11 | 7.8K | 137,728 | D | ↗ |
| 2024-11-22 | Burnett Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 16,023 | 3.64 | 58.3K | 218,500 | D | ↗ |
| 2024-11-19 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 1,775 | 9.68 | 17.2K | 181,373 | D | ↗ |
| 2024-11-18 | Matsuda Masaru | Officer | A-Award | A | Common Stock | 4,875 | 0.00 | — | 183,148 | D | ↗ |
| 2024-11-15 | Burnett Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 100 | 3.64 | 364.00 | 234,523 | D | ↗ |
| 2024-11-14 | Burnett Patrick | Officer | M-Exempt | A | Common Stock | 18,377 | 0.00 | — | 147,046 | D | ↗ |
| 2024-11-11 | Curran Terrie | Director | S-Sale | D | Common Stock | 8,687 | 10.85 | 94.2K | 10,139 | D | ↗ |
| 2024-11-04 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 13,871 | 8.68 | 120.5K | 832,392 | D | ↗ |
| 2024-11-04 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 5,015 | 8.68 | 43.6K | 178,273 | D | ↗ |
| 2024-11-04 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 15,441 | 8.68 | 134.1K | 179,418 | D | ↗ |
| 2024-11-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 8.65 | 86.5K | 171,944 | D | ↗ |
| 2024-10-02 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 3,725 | 10.01 | 37.3K | 136,635 | D | ↗ |
| 2024-10-01 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 9.26 | 92.6K | 181,944 | D | ↗ |
| 2024-09-24 | Topper David Joseph | Officer | S-Sale | D | Common Stock | 11,626 | 9.48 | 110.3K | 158,374 | D | ↗ |
| 2024-09-21 | Topper David Joseph | Officer | A-Award | A | Common Stock | 60,000 | 0.00 | — | 170,000 | D | ↗ |
| 2024-09-03 | Welgus Howard G. | Director | S-Sale | D | Common Stock | 10,000 | 10.77 | 107.7K | 191,944 | — | ↗ |
| 2024-08-19 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 1,728 | 8.29 | 14.3K | 194,859 | — | ↗ |
| 2024-08-02 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 14,487 | 9.02 | 130.6K | 846,263 | — | ↗ |
| 2024-08-02 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 5,220 | 9.02 | 47.1K | 183,288 | — | ↗ |
| 2024-08-02 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 13,206 | 9.02 | 119.1K | 196,587 | — | ↗ |
| 2024-08-01 | Welgus Howard G. | Director | M-Exempt | D | Stock Option (right to buy) | 6,614 | 1.68 | 11.1K | 0 | — | ↗ |
| 2024-07-01 | Welgus Howard G. | Director | M-Exempt | A | Common Stock | 4,319 | 1.68 | 7.3K | 190,339 | — | ↗ |
| 2024-06-14 | Welgus Howard G. | Director | A-Award | A | Stock Option (right to buy) | 27,052 | 8.63 | 233.5K | 27,052 | — | ↗ |
| 2024-06-14 | Leonard Keith R | Director | A-Award | A | Common Stock | 10,139 | 0.00 | — | 18,826 | — | ↗ |
| 2024-06-14 | LIN SUE-JEAN | Director | A-Award | A | Common Stock | 10,139 | 0.00 | — | 19,126 | — | ↗ |
| 2024-06-14 | Krishnamohan Neha | Director | A-Award | A | Common Stock | 10,139 | 0.00 | — | 15,746 | — | ↗ |
| 2024-06-14 | Heron Patrick J | Director / 10% Owner | A-Award | A | Common Stock | 10,139 | 0.00 | — | 18,826 | — | ↗ |
| 2024-06-14 | Gilbert Halley E | Director | A-Award | A | Common Stock | 10,139 | 0.00 | — | 18,826 | — | ↗ |
| 2024-06-14 | Curran Terrie | Director | A-Award | A | Common Stock | 10,139 | 0.00 | — | 18,826 | — | ↗ |
| 2024-06-14 | CHAUDHURI BHASKAR | Director | A-Award | A | Common Stock | 10,139 | 0.00 | — | 860,217 | — | ↗ |
| 2024-06-04 | Welgus Howard G. | Director | M-Exempt | A | Common Stock | 3,542 | 1.68 | 6.0K | 173,742 | — | ↗ |
| 2024-05-31 | Watanabe Todd Franklin | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 1.69 | 6.8K | 836,392 | D | ↗ |
| 2024-05-31 | Matsuda Masaru | Officer | P-Purchase | A | Common Stock | 4,000 | 1.69 | 6.8K | 185,373 | D | ↗ |
| 2024-05-30 | Burnett Patrick | Officer | M-Exempt | A | Common Stock | 23,000 | 0.00 | — | 232,793 | — | ↗ |
| 2024-05-29 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 49,952 | 8.72 | 435.4K | 209,793 | — | ↗ |
| 2024-05-28 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 1,775 | 9.01 | 16.0K | 188,508 | — | ↗ |
| 2024-05-27 | Matsuda Masaru | Officer | A-Award | A | Common Stock | 4,875 | 0.00 | — | 190,283 | — | ↗ |
| 2024-05-17 | Edwards Larry Todd | Officer | S-Sale | D | Common Stock | 7,640 | 8.98 | 68.6K | 140,360 | — | ↗ |
| 2024-05-16 | Edwards Larry Todd | Officer | A-Award | A | Common Stock | 60,000 | 0.00 | — | 148,000 | — | ↗ |
| 2024-05-02 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 13,783 | 8.74 | 120.4K | 860,750 | — | ↗ |
| 2024-05-02 | Moore Matthew Richard | Officer | S-Sale | D | Common Stock | 4,681 | 8.74 | 40.9K | 145,505 | — | ↗ |
| 2024-05-02 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 5,016 | 8.74 | 43.8K | 185,408 | — | ↗ |
| 2024-05-02 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 9,555 | 8.74 | 83.5K | 259,745 | — | ↗ |
| 2024-05-01 | Moore Matthew Richard | Officer | A-Award | A | Common Stock | 4,166 | 0.00 | — | 150,186 | — | ↗ |
| 2024-04-10 | Topper David Joseph | Officer | A-Award | A | Stock Option (right to buy) | 310,000 | 12.34 | 3.83M | 310,000 | — | ↗ |
| 2024-03-04 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 14,903 | 11.12 | 165.7K | 874,533 | — | ↗ |
| 2024-03-04 | Moore Matthew Richard | Officer | S-Sale | D | Common Stock | 3,468 | 11.12 | 38.6K | 146,020 | — | ↗ |
| 2024-03-04 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 3,760 | 11.12 | 41.8K | 190,424 | — | ↗ |
| 2024-03-04 | Heron Patrick J | Director | P-Purchase | A | Common Stock | 21,052 | 9.50 | 200.0K | 8,785,284 | — | ↗ |
| 2024-03-04 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 4,782 | 11.12 | 53.2K | 269,300 | — | ↗ |
| 2024-02-28 | Watanabe Todd Franklin | Director / Officer | S-Sale | D | Common Stock | 2,465 | 10.60 | 26.1K | 889,436 | — | ↗ |
| 2024-02-13 | Watanabe Todd Franklin | Director / Officer | A-Award | A | Common Stock | 116,100 | 0.00 | — | 891,901 | — | ↗ |
| 2024-02-13 | Smither John W | Officer | A-Award | A | Common Stock | 8,572 | 0.00 | — | 11,365 | — | ↗ |
| 2024-02-13 | Moore Matthew Richard | Officer | A-Award | A | Common Stock | 26,666 | 0.00 | — | 81,256 | — | ↗ |
| 2024-02-13 | Matsuda Masaru | Officer | D-Return | D | Stock Option (right to buy) | 35,300 | 17.67 | 623.8K | 0 | — | ↗ |
| 2024-02-13 | Burnett Patrick | Officer | A-Award | A | Common Stock | 9,600 | 0.00 | — | 222,632 | — | ↗ |
| 2024-01-12 | Watanabe Todd Franklin | Director / Officer | A-Award | A | Stock Option (right to buy) | 410,000 | 3.64 | 1.49M | 410,000 | — | ↗ |
| 2024-01-12 | Moore Matthew Richard | Officer | A-Award | A | Common Stock | 28,000 | 0.00 | — | 54,590 | — | ↗ |
| 2024-01-12 | Matsuda Masaru | Officer | A-Award | A | Stock Option (right to buy) | 176,000 | 3.64 | 640.6K | 176,000 | — | ↗ |
| 2024-01-12 | Edwards Larry Todd | Officer | A-Award | A | Common Stock | 28,000 | 0.00 | — | 88,000 | — | ↗ |
| 2024-01-12 | Burnett Patrick | Officer | A-Award | A | Common Stock | 28,000 | 0.00 | — | 85,032 | — | ↗ |
| 2024-01-02 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 1,325 | 3.54 | 4.7K | 57,032 | — | ↗ |
| 2023-12-20 | Watanabe Todd Franklin | Director / Officer | G-Gift | A | Common Stock | 6,563 | 0.00 | — | 24,413 | — | ↗ |
| 2023-12-01 | Watanabe Todd Franklin | Director / Officer | M-Exempt | A | Common Stock | 59,525 | 1.68 | 100.0K | 513,682 | — | ↗ |
| 2023-11-21 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 1,850 | 1.98 | 3.7K | 46,634 | — | ↗ |
| 2023-11-18 | Matsuda Masaru | Officer | A-Award | A | Common Stock | 4,875 | 0.00 | — | 48,484 | — | ↗ |
| 2023-10-24 | Frazier Life Sciences VIII, L.P. | 10% Owner | P-Purchase | A | Common Stock | 80,000 | 2.50 | 200.0K | 8,764,232 | — | ↗ |
| 2023-09-27 | Edwards Larry Todd | Officer | A-Award | A | Stock Option (right to buy) | 240,000 | 5.58 | 1.34M | 240,000 | — | ↗ |
| 2023-08-31 | Smither John W | Officer | — | D | Stock Option (right to buy) | 8,379 | 27.61 | 231.3K | 0 | — | ↗ |
| 2023-08-29 | Moore Matthew Richard | Officer | A-Award | A | Stock Option (Right to Buy) | 12,500 | 28.72 | 359.0K | 12,500 | — | ↗ |
| 2023-08-21 | Burnett Patrick | Officer | S-Sale | D | Common Stock | 300 | 7.05 | 2.1K | 59,662 | — | ↗ |
| 2023-05-31 | Welgus Howard G. | Director | A-Award | A | Common Stock | 4,375 | 0.00 | — | 170,200 | — | ↗ |
| 2023-05-31 | Watanabe Todd Franklin | Director / Officer | P-Purchase | A | Common Stock | 1,463 | 6.38 | 9.3K | 515,145 | — | ↗ |
| 2023-05-31 | Matsuda Masaru | Officer | S-Sale | D | Common Stock | 1,830 | 7.80 | 14.3K | 42,146 | — | ↗ |
| 2023-05-31 | Leonard Keith R | Director | A-Award | A | Common Stock | 4,375 | 0.00 | — | 8,687 | — | ↗ |
| 2023-05-31 | LIN SUE-JEAN | Director | A-Award | A | Common Stock | 4,375 | 0.00 | — | 8,987 | — | ↗ |
| 2023-05-31 | Krishnamohan Neha | Director | A-Award | A | Common Stock | 4,375 | 0.00 | — | 5,607 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-8.4K
Shares Outstanding
125.07M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Todd Franklin Watanabe President and Chief Executive Officer | 713.3K | — | 2.07M | 3.85M | 579.6K | 14.0K | 7.22M | 81.91% | ↗ |
| 2 | 2025 | L. Todd Edwards Chief Commercial Officer | 535.0K | — | 753.0K | 1.38M | 334.4K | 27.8K | 3.03M | 70.39% | ↗ |
| 3 | 2025 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 535.0K | — | 753.0K | 1.38M | 334.4K | 14.0K | 3.02M | 70.72% | ↗ |
| 4 | 2025 | Masaru Matsuda, J.D. Chief Legal Officer | 495.2K | — | 465.5K | 865.0K | 278.5K | 14.0K | 2.12M | 62.81% | ↗ |
| 5 | 2025 | David Topper Former Chief Financial Officer | 196.5K | — | 465.5K | 865.0K | — | 419.8K | 1.95M | 68.35% | ↗ |
| 6 | 2025 | Latha Vairavan | 419.5K | — | 440.4K | 839.5K | 213.4K | 12.0K | 1.92M | 66.49% | ↗ |
| 7 | 2024 | David Topper Chief Financial Officer | 364.8K | — | 1.85M | 2.77M | 296.6K | 23.4K | 5.31M | 87.11% | ↗ |
| 8 | 2024 | David Topper Former Chief Financial Officer | 364.8K | — | 1.85M | 2.77M | 296.6K | 23.4K | 5.31M | 87.11% | ↗ |
| 9 | 2024 | Todd Franklin Watanabe President and Chief Executive Officer | 660.9K | — | 1.41M | 1.05M | 549.8K | 19.9K | 3.69M | 66.64% | ↗ |
| 10 | 2024 | Todd Franklin Watanabe President and Chief Executive Officer | 660.9K | — | 1.41M | 1.05M | 549.8K | 19.9K | 3.69M | 66.64% | ↗ |
| 11 | 2024 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 504.2K | — | 989.3K | 709.0K | 293.3K | 17.3K | 2.51M | 67.58% | ↗ |
| 12 | 2024 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 504.2K | — | 989.3K | 709.0K | 293.3K | 17.3K | 2.51M | 67.58% | ↗ |
| 13 | 2024 | John Smither Chief Financial Officer | 183.3K | — | 1.05M | 759.7K | 105.6K | — | 2.10M | 86.26% | ↗ |
| 14 | 2024 | L. Todd Edwards Chief Commercial Officer | 516.4K | — | 679.1K | 452.1K | 300.3K | 17.2K | 1.97M | 57.57% | ↗ |
| 15 | 2024 | L. Todd Edwards Chief Commercial Officer | 516.4K | — | 679.1K | 452.1K | 300.3K | 17.2K | 1.97M | 57.57% | ↗ |
| 16 | 2024 | Masaru Matsuda, J.D. General Counsel | 465.5K | — | 535.5K | 452.1K | 268.1K | 16.4K | 1.74M | 56.84% | ↗ |
| 17 | 2024 | Masaru Matsuda, J.D. Chief Legal Officer | 465.5K | — | 535.5K | 452.1K | 268.1K | 16.4K | 1.74M | 56.84% | ↗ |
| 18 | 2023 | Todd Franklin Watanabe President and Chief Executive Officer | 633.5K | — | 1.38M | 2.54M | 354.1K | 20.1K | 4.94M | 79.58% | ↗ |
| 19 | 2023 | Todd Franklin Watanabe President and Chief Executive Officer | 633.5K | — | 1.38M | 2.54M | 354.1K | 20.1K | 4.94M | 79.58% | ↗ |
| 20 | 2023 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 477.3K | — | 332.2K | 611.2K | 230.9K | 14.8K | 1.67M | 56.62% | ↗ |
| 21 | 2023 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 477.3K | — | 332.2K | 611.2K | 230.9K | 14.8K | 1.67M | 56.62% | ↗ |
| 22 | 2023 | L. Todd Edwards Chief Commercial Officer | 131.3K | — | 334.8K | 938.9K | 241.9K | 11.1K | 1.66M | 76.83% | ↗ |
| 23 | 2023 | Masaru Matsuda, J.D. General Counsel | 434.0K | — | 332.2K | 611.2K | 210.0K | 15.8K | 1.60M | 58.85% | ↗ |
| 24 | 2023 | John Smither Chief Financial Officer | 200.9K | — | — | 738.2K | 97.2K | — | 1.04M | 71.24% | ↗ |
| 25 | 2022 | Masaru Matsuda, J.D. General Counsel | 415.0K | — | 1.12M | 3.39M | 190.9K | 20.3K | 5.14M | 87.82% | ↗ |
| 26 | 2022 | Todd Franklin Watanabe President and Chief Executive Officer | 590.0K | — | 1.25M | 2.31M | 407.1K | 17.0K | 4.58M | 77.87% | ↗ |
| 27 | 2022 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 457.2K | — | 314.5K | 579.6K | 210.3K | 22.5K | 1.58M | 56.44% | ↗ |
| 28 | 2022 | Kenneth Lock Chief Commercial Officer | 392.5K | — | 235.0K | 434.4K | 180.6K | 27.6K | 1.27M | 52.71% | ↗ |
| 29 | 2022 | Scott Burrows Chief Financial Officer | 386.7K | — | 235.0K | 434.4K | 177.9K | 12.2K | 1.25M | 53.72% | ↗ |
| 30 | 2021 | John Smither Chief Financial Officer | 100.0K | — | 755.2K | 5.38M | — | 10.8K | 6.25M | 98.23% | ↗ |
| 31 | 2021 | Todd Franklin Watanabe President and Chief Executive Officer | 525.0K | — | 1.06M | 2.28M | 393.8K | 21.4K | 4.28M | 78.05% | ↗ |
| 32 | 2021 | Matthew Moore Chief Business Officer | 356.7K | — | — | 3.23M | 178.4K | 25.0K | 3.79M | 85.24% | ↗ |
| 33 | 2021 | Scott Burrows Chief Financial Officer | 330.8K | — | 90.8K | 1.48M | 165.4K | 11.6K | 2.08M | 75.59% | ↗ |
| 34 | 2021 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 437.5K | — | 308.2K | 662.8K | 218.8K | 43.9K | 1.67M | 58.11% | ↗ |
| 35 | 2021 | Patrick E. Burnett Chief Medical Officer | 437.5K | — | 308.2K | 662.8K | 218.8K | 43.9K | 1.67M | 58.11% | ↗ |
| 36 | 2021 | Kenneth Lock Chief Commercial Officer | 373.3K | — | 308.2K | 662.8K | 186.7K | 33.4K | 1.56M | 62.07% | ↗ |
| 37 | 2021 | David W. Osborne Chief Technical Officer | 375.0K | — | 308.2K | 662.8K | 187.5K | 22.1K | 1.56M | 62.42% | ↗ |
| 38 | 2020 | Patrick E. Burnett, M.D., Ph.D. Chief Medical Officer | 170.8K | — | 867.3K | 5.60M | 209.1K | 696.00 | 6.85M | 94.44% | ↗ |
| 39 | 2020 | Patrick E. Burnett Chief Medical Officer | 170.8K | — | 867.3K | 5.60M | 209.1K | 696.00 | 6.85M | 94.44% | ↗ |
| 40 | 2020 | Todd Franklin Watanabe President and Chief Executive Officer | 441.7K | — | 800.7K | 1.22M | 281.6K | 11.4K | 2.75M | 73.29% | ↗ |
| 41 | 2020 | Kenneth Lock Chief Commercial Officer | 335.0K | — | 248.5K | 504.9K | 170.9K | 8.4K | 1.27M | 59.43% | ↗ |
| 42 | 2020 | Kenneth A. Lock Chief Commercial Officer | 335.0K | — | 248.5K | 504.9K | 170.9K | 8.4K | 1.27M | 59.43% | ↗ |
| 43 | 2019 | Todd Franklin Watanabe President and Chief Executive Officer | 390.0K | — | — | 580.5K | 169.8K | — | 1.14M | 50.91% | ↗ |
| 44 | 2019 | Kenneth A. Lock Chief Commercial Officer | 66.9K | — | — | 674.8K | 24.3K | — | 766.1K | 88.08% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Todd Franklin Watanabe | President, Chief Executive Officer & Director | 1M | male |
| L. Todd Edwards | Executive Vice President & Chief Commercial Officer | 897.2K | male |
| Patrick E. Burnett | Executive Vice President & Chief Medical Officer | 883.4K | — |
| Masaru Matsuda | Executive VP, Chief Legal Officer & Corporate Secretary | 787.7K | male |
| Latha Vairavan | Senior Vice President & Chief Financial Officer | 644.9K | female |
| Bhaskar Chaudhuri | Co-Founder & Director Emeritus | 60.1K | — |
| Aleen Hosdaghian | Vice President of Marketing | — | female |
| Brian Schoelkopf | Head of Investor Relations | — | male |
| Kent Taylor | Senior Vice President of Sales | — | male |
| Rajvir Madan | Chief Digital & Technology Officer | — | male |
| Steve Arias | Vice President of Compliance & Privacy | — | male |
| Amanda Sheldon | Head of Corporate Communications | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-04-08 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-12-11 | 2026-01-12 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2023-09-15 | 2023-10-15 | Josh Gottheimer | NJ05 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2023-04-17 | 2023-05-19 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2022-06-15 | 2022-07-22 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ARQT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
